With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...
Vektor Medical, a medical technology company headquartered in San Diego redefining how arrhythmias are understood and treated, announced it has received the US Food and Drug Administration 510(k) ...
With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results